GlassScriptPhysician profile
Rene Castro
NPI 1720605892
$762.93
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $580 · 2023: $57.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $152.91 | 2022 | |
| Paratek Pharmaceuticals, INC. | $124.99 | 2021 | |
| Lilly USA, LLC | $124.98 | 2022 | |
| Boston Scientific Corporation | $110.03 | 2022 | |
| Glaxosmithkline, LLC. | $72.76 | 2022 | |
| Genzyme Corporation | $57.88 | 2023 | |
| Novo Nordisk INC | $33.45 | 2022 | |
| Pharmacosmos Therapeutics INC. | $24.14 | 2022 | |
| Sanofi-Aventis U.S. LLC | $22.97 | 2022 | |
| Incyte Corporation | $21.15 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $17.67 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rene Castro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.